QVAR® (beclomethasone dipropionate HFA) – Revised indication
September 29, 2017 – The FDA approved a revision to the indication for QVAR (beclomethasone dipropionate HFA). Information regarding asthma patients requiring oral corticosteroid therapy was removed.
Download PDF
